Scientists track radioactive drug through healthy volunteers
Knowledge-focused
Completed
This study aimed to understand how the body absorbs, breaks down, and eliminates a new drug candidate (TGRX-678) for chronic myeloid leukemia. Six healthy Chinese male volunteers received a single, traceable dose of the drug. Researchers measured where the drug went and how it le…
Phase: PHASE1 • Sponsor: Shenzhen TargetRx Co., Ltd. • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC